FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Fenoldopam Mesylate (Corlopam) Injection, USP
Status: Discontinuation
»Therapeutic Categories: Cardiovascular

Expand all

Hospira, Inc. (New 11/16/2020)

Company Contact Information:
844-646-4398

Presentation Posting Date Related Information
20 mg/2 mL (10 mg/mL); Glass Ampul (NDC 00409-2304-02) 11/16/2020 Discontinuation of the manufacture of the ampul, equivalent vial available.
10 mg/mL (10 mg/mL); Glass Ampul (NDC 00409-2304-01) 11/16/2020 Discontinuation of the manufacture of the ampul, equivalent vial available.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English